MediPal Holdings Corporation (TYO:7459)
Japan flag Japan · Delayed Price · Currency is JPY
3,228.00
+30.00 (0.94%)
Nov 13, 2026, 3:30 PM JST

MediPal Holdings Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
3,889,4123,817,3543,671,3283,558,7323,360,0083,290,921
Revenue Growth
3.88%3.98%3.16%5.91%2.10%2.48%
Gross Profit
262,030260,988255,759246,655224,305217,445
Operating Income
52,42853,18455,61147,33148,97445,625
Net Income
43,47142,53440,27941,47438,80629,423
Earnings Per Share
212.33206.67193.19195.83179.12131.41
EPS Growth
8.35%6.98%-1.35%9.33%36.31%23.04%

Revenue by Segment

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Wholesale Business of Medical Pharmaceuticals and Related Products
2,522,7692,466,1092,370,2452,295,7952,189,6672,177,002
Businesses Related to the Wholesale of Veterinary Drugs and Raw Materials for Food Processing
123,213117,328116,861114,02373,95471,858
Cosmetics, Daily Necessities, and Over-The-Counter Pharmaceutical Wholesale Business
1,247,4601,237,8461,188,0971,151,9661,104,1521,045,735
Unallocated Adjustment
-4,030-3,930-3,876-3,051-7,766-3,675
Total
3,889,4123,817,3533,671,3273,558,7333,360,0073,290,920

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
269,218289,073261,407230,470195,031261,920
Total Debt
144,400----30,078
Net Cash (Debt)
124,818289,073261,407230,470195,031231,842
Net Cash Growth
-54.88%10.58%13.42%18.17%-15.88%9.91%
Net Cash Per Share
609.661404.601253.811088.23901.481039.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
54,14846,55260,55961,84316,14661,216
Capital Expenditures
-14,130-6,619-8,861-15,560-10,483-15,958
Free Cash Flow
40,01839,93351,69846,2835,66345,258
Free Cash Flow Growth
6.14%-22.76%11.70%717.29%-87.49%109.47%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
6.74%6.84%6.97%6.93%6.68%6.61%
Operating Margin
1.35%1.39%1.52%1.33%1.46%1.39%
Pretax Margin
2.06%2.14%2.09%2.10%2.09%1.74%
Profit Margin
1.12%1.11%1.10%1.17%1.16%0.89%
FCF Margin
1.03%1.05%1.41%1.30%0.17%1.38%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
88.00066.00062.00060.00046.00044.000
Dividend Per Share Growth
33.33%6.45%3.33%30.44%4.54%4.76%
Dividend Yield
2.73%2.25%2.66%2.59%2.55%2.18%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
15.2014.1412.0611.759.7614.38
Forward PE
13.0915.8013.3613.8712.1513.42
P/FCF Ratio
16.5115.069.3910.5366.899.35
PS Ratio
0.170.160.130.140.110.13